BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
346 results:

  • 1. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
    Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
    Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Application research of radiomics in colorectal cancer: A bibliometric study.
    Yang L; Wang B; Shi X; Li B; Xie J; Wang C
    Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
    Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
    J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
    Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
    Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiation Dose Does Not Affect the Predictive Value of thyroid Biopsy for Diagnosing Papillary thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
    McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
    Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
    Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
    JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Diagnostic Value of
    Cui B; Wu Z; Yu B; Li Y; Liu H
    Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The correlation between small papillary thyroid cancers and gamma radionuclides Cs-137, Th-232, U-238 and K-40 using spatially-explicit, register-based methods.
    Bayadsi H; Brink PVD; Erlandsson M; Gudbjornsdottir S; Sebraoui S; Koorem S; Nordin P; Hennings J; Englund O
    Spat Spatiotemporal Epidemiol; 2023 Nov; 47():100618. PubMed ID: 38042537
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
    Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
    Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
    [No Abstract]    [Full Text] [Related]  

  • 10. Diagnostic Performance of thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
    Yucel S; Balci IG; Tomak L
    Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated thyroid cancers.
    Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
    Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
    [No Abstract]    [Full Text] [Related]  

  • 12. Therapeutic inhibition of ATR in differentiated thyroid cancer.
    Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.
    de Sousa MSA; Nunes IN; Christiano YP; Sisdelli L; Cerutti JM
    Rev Endocr Metab Disord; 2024 Feb; 25(1):35-51. PubMed ID: 37874477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Correlation between preoperative platelet parameters and clinicopathological features of differentiated thyroid cancer].
    Wang X; Liu W; Zhao M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Oct; 37(10):796-800. PubMed ID: 37828882
    [No Abstract]    [Full Text] [Related]  

  • 15. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
    Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
    Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary thyroid Carcinoma.
    Chou A; Qiu MR; Crayton H; Wang B; Ahadi MS; Turchini J; Clarkson A; Sioson L; Sheen A; Singh N; Clifton-Bligh RJ; Robinson BG; Gild ML; Tsang V; Leong D; Sidhu SB; Sywak M; Delbridge L; Aniss A; Wright D; Graf N; Kumar A; Rathi V; Benitez-Aguirre P; Glover AR; Gill AJ
    Mod Pathol; 2023 Dec; 36(12):100329. PubMed ID: 37716505
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
    Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
    Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated thyroid cancer.
    Ju G; Sun Y; Wang H; Zhang X; Mu Z; Sun D; Huang L; Lin R; Xing T; Cheng W; Liang J; Lin YS
    J Clin Endocrinol Metab; 2024 Jan; 109(2):505-515. PubMed ID: 37622214
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transoral endoscopic and robotic thyroidectomy for thyroid cancer: the mid-term oncological outcome.
    Chen YH; Chao WP; Wang SH; Huang YT; Ng SC
    Surg Endosc; 2023 Oct; 37(10):7829-7838. PubMed ID: 37605012
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.